Poor prognosis of arthritis-associated pyoderma gangrenosum

被引:30
作者
Charles, CA
Bialy, TL
Falabella, AF
Eaglstein, WH
Kerdel, FA
Kirsner, RS
机构
[1] Univ Miami, Sch Med, Dept Dermatol & Cutaneous Surg, Vet Adm Med Ctr, Miami, FL 33125 USA
[2] Univ Miami, Sch Med, Dept Surg, Miami, FL 33125 USA
[3] Univ Miami, Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33125 USA
[4] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA USA
[5] Vet Adm Med Ctr, Miami, FL 33125 USA
关键词
D O I
10.1001/archderm.140.7.861
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The association between pyoderma. gangrenosum (PG) and arthritis is well established. We have observed a refractory population of patients with arthritis-associated PG (PGA). We, therefore,'tested the hypothesis that differences exist in response to treatment in patients with PGA compared with patients with PG without arthritis. Observations: We performed a review of patients with PG during a 2-year period. Patients had noninfectious chronic ulcerations clinically typical for PG, exclusion of relevant differential diagnoses, and consistent histopathological features. Outcomes compared between patients with arthritis (PGA) and without arthritis (PG) in-eluded complete healing, percentage change in wound size, and duration of therapy. Of 10 PG ulcers, 7 healed, compared with 2 of 8 PGA ulcers. There was a greater mean percentage decrease in wound size in the PG vs the PGA ulcers (78.9% vs 23.4%; P =. 10) and a shorter mean duration of treatment (8.7 vs 14.8 months; P =. 18). Conclusions: The ulcers of patients with PGA seem more refractory to treatment than the ulcers of patients with PG alone. Those with PGA ulcers represent a refractory subset of patients, and the ulcers are possibly secondary to unique pathophysiological features.
引用
收藏
页码:861 / 864
页数:4
相关论文
共 15 条
[1]   DECREASED PLASMA FIBRINOLYSIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
BELCH, JJF ;
MCARDLE, B ;
MADHOK, R ;
MCLAUGHLIN, K ;
CAPELL, HA ;
FORBES, CD ;
STURROCK, RD .
ANNALS OF THE RHEUMATIC DISEASES, 1984, 43 (06) :774-777
[2]   A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions [J].
Bennett, ML ;
Jackson, JM ;
Jorizzo, JL ;
Fleischer, AB ;
White, WL ;
Callen, JP .
MEDICINE, 2000, 79 (01) :37-46
[3]   PYODERMA GANGRENOSUM AND RELATED DISORDERS [J].
CALLEN, JP .
MEDICAL CLINICS OF NORTH AMERICA, 1989, 73 (05) :1247-1261
[4]  
GAYLARDE PM, 1990, BRIT J RHEUMATOL, V29, P142
[5]   PYODERMA GANGRENOSUM - CLINICAL AND LABORATORY FINDINGS IN 15 PATIENTS WITH SPECIAL REFERENCE TO POLYARTHRITIS [J].
HOLT, PJA ;
DAVIES, MG ;
SAUNDERS, KC ;
NUKI, G .
MEDICINE, 1980, 59 (02) :114-133
[6]   Pyoderma gangrenosum associated with Crohn disease:: effect of TNF-α blockade with infliximab [J].
Ljung, T ;
Staun, M ;
Grove, O ;
Fausa, O ;
Vatn, MH ;
Hellström, PM .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) :1108-1110
[7]  
McRorie ER, 1998, BRIT J RHEUMATOL, V37, P1295
[8]   THE EFFECTIVE MANAGEMENT OF VENOUS ULCERATION [J].
NEGUS, D ;
FRIEDGOOD, A .
BRITISH JOURNAL OF SURGERY, 1983, 70 (10) :623-627
[9]   Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy [J].
Olivieri, I ;
Costa, AM ;
Cantini, F ;
Niccoli, L ;
Marini, R ;
Ferri, S .
ARTHRITIS AND RHEUMATISM, 1996, 39 (06) :1062-1065
[10]  
POWELL FC, 1985, Q J MED, V55, P173